Home/Filings/4/0001179110-19-008261
4//SEC Filing

Goyal Vikas 4

Accession 0001179110-19-008261

CIK 0001679363other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 7:23 PM ET

Size

13.5 KB

Accession

0001179110-19-008261

Insider Transaction Report

Form 4
Period: 2019-07-01
Goyal Vikas
Director
Transactions
  • Conversion

    Common Stock

    2019-07-01+1,469,9501,469,950 total(indirect: By S.R. One, Limited)
  • Conversion

    Series B Preferred Stock

    2019-07-01830,4890 total(indirect: By S.R. One, Limited)
    Common Stock (830,489 underlying)
  • Conversion

    Common Stock

    2019-07-01+830,4892,300,439 total(indirect: By S.R. One, Limited)
  • Conversion

    Series A Preferred Stock

    2019-07-011,469,9500 total(indirect: By S.R. One, Limited)
    Common Stock (1,469,950 underlying)
  • Purchase

    Common Stock

    2019-07-01$15.00/sh+333,333$4,999,9952,633,772 total(indirect: By S.R. One, Limited)
Footnotes (3)
  • [F1]Each share of the issuer's Series A Preferred Stock automatically converted into one share of the issuer's Common Stock on July 1, 2019 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-231837) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.
  • [F2]S.R. One, Limited, an indirect wholly-owned subsidiary of GlaxoSmithKline plc, is the record holder of the shares reported herein. Vikas Goyal holds the title of Principal at S.R. One, Limited and is an employee of GlaxoSmithKline LLC, a wholly-owned subsidiary of GlaxoSmithKline plc. Mr. Goyal disclaims beneficial ownership of all the shares held by S.R. One, Limited and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
  • [F3]Each share of the issuer's Series B Preferred Stock automatically converted into one share of the issuer's Common Stock on July 1, 2019 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

Issuer

Morphic Holding, Inc.

CIK 0001679363

Entity typeother

Related Parties

1
  • filerCIK 0001721017

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 7:23 PM ET
Size
13.5 KB